Alignment Healthcare Exceeds Q2 Guidance, Raises Full-Year Outlook on Strong Growth

summarizeSummary

Alignment Healthcare reported strong second-quarter 2026 financial results, exceeding its own guidance across all key metrics, driven by robust revenue and membership growth. The company also raised its full-year guidance, indicating a positive outlook.

check_boxKey Events · Earnings and Guidance · ALHC

• Strong Q2 2026 Financial Performance

  The company exceeded the high end of its guidance, reporting $1,335.6 million in total revenue (up 31.6% year-over-year), $182.9 million in adjusted gross profit (up 35.3% year-over-year), and $68.1 million in adjusted EBITDA (up 48.4% year-over-year). Net income more than doubled to $36.6 million.

• Significant Membership Growth

  Medicare Advantage membership grew 31.5% year-over-year, reaching approximately 294,100 members by the end of the second quarter.

• Raised Full-Year Guidance

  Alignment Healthcare increased the midpoint of all its full-year guidance metrics, including membership, revenue, adjusted gross profit, and adjusted EBITDA, signaling continued confidence in its operational performance.

auto_awesomeAnalysis · ALHC · Finance

This 8-K announces Alignment Healthcare's Q2 2026 earnings, which significantly surpassed the high end of the company's own guidance. Key metrics like revenue, adjusted gross profit, and adjusted EBITDA showed substantial year-over-year growth, with net income more than doubling. The company's decision to raise the midpoint of all full-year guidance metrics, including membership and revenue, suggests strong operational momentum and improved future profitability expectations. This positive financial update is likely to be well-received by investors.